International variation in prostate cancer incidence and mortality rates.

By Melissa M. Center, A. Jemal, J. Lortet-Tieulent, Elizabeth E. Ward, J. Ferlay, O. Brawley, F. Bray. European Urology, 2012

1,551 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/c7312af67694c3fd9ab6b7a97b9b0a4ee4b30606

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

In Pulmonary and Respiratory Medicine

Citations in the corpus

International variations and trends in renal cell carcinoma incidence and mortality. (2015, background): “between areas with higher and lower resources is also evident, with greater mortality declines in Western versus Eastern Europe and North versus South America; these are noted for other urologic cancers, including testicular and prostate cancer [31,32].”
Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities (2016, background): “Black men and Jamaican men of African descent have the highest prostate cancer incidence rates worldwide, which may reflect differences in inherited genetic susceptibility.(94-97) Similarly, black men have the highest mortality rate for prostate cancer of any racial or ethnic group in the United Sta”
Guidelines on Prostate Cancer (2013, background): “J Endocrinol Invest 2013 Feb;36(2):132-9.”
Global cancer statistics, 2012 (2015, background): “Smoking, alcohol use, smokeless tobacco use, and HPV infection are the major risk factors for oral cavity cancer, with smoking and alcohol having synergistic effects.131,132 The contribution of each of these risk factors to the burden varies across regions.45 Smoking is estimated to account for abou”
Global Cancer Incidence and Mortality Rates and Trends—An Update (2015, background): “These decreases are thought to be due to improved treatment and/or early detection, although the contribution of PSA testing is debated (42); a large randomized trial in Europe found a significant reduction in mortality associated with PSA testing, whereas a U.”
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2024, background): “…Mortality rates have decreased in most high ‐ income countries since the mid ‐ 1990s, including those in Northern America, Oceania, and Northern and Western Europe, 88,98,100 likely reflecting advancements in effective treatment and earlier detection through increased testing of asymptomatic men.”